Technical appraisal of solar home systems in Bangladesh: A field investigation

Solar Home System (SHS) based rural electrification has experienced a considerable growth in Bangladesh since the start of the Rural Electrification and Renewable Energy Development Project (REREDP) in 2003. The initial target of 50,000 SHS installations in off-grid areas was achieved within 2.5 years, 3 years ahead of schedule. After achieving a revised target of 200,000 SHSs, ahead of schedule in early 2009, a new target of 1 million SHS installations by 2012 was set. The installation of about 0.5 million systems by March 2010 indicates that the current target may well be achieved before the deadline. The size of the SHS market and its impact on the regeneration of the rural economy make it necessary to investigate the quality and reliability of the installed SHSs, if the continued success of the initiative is to be maintained. This paper reports on the findings from a field-based technical appraisal of SHS installations in Bangladesh. Sixty geographically dispersed installation sites were visited. Physical characteristics of the SHSs and their system components were tested to ascertain compliance with and deviations from the approved specifications. Despite the overwhelming success of the REREDP project, the study revealed various shortcomings. Notable among these are: incompatible and sub-optimal component configurations, faulty installations and a lack of effective quality assurance mechanism. The findings are contextualized and the ways to address the identified shortcomings are discussed

The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Funding Bill & Melinda Gates Foundation